Citigroup’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $515M | Buy |
|
|||||
|
2025
Q1 | $410M | Buy |
|
|||||
|
2024
Q4 | $245M | Sell |
|
|||||
|
2024
Q3 | $288M | Sell |
|
|||||
|
2024
Q2 | $424M | Buy |
|
|||||
|
2024
Q1 | $355M | Buy |
|
|||||
|
2023
Q4 | $300M | Sell |
|
|||||
|
2023
Q3 | $285M | Sell |
|
|||||
|
2023
Q2 | $299M | Buy |
|
|||||
|
2023
Q1 | $258M | Buy |
|
|||||
|
2022
Q4 | $222M | Buy |
|
|||||
|
2022
Q3 | $183M | Sell |
|
|||||
|
2022
Q2 | $243M | Buy |
|
|||||
|
2022
Q1 | $257M | Buy |
|
|||||
|
2021
Q4 | $244M | Buy |
|
|||||
|
2021
Q3 | $136M | Sell |
|
|||||
|
2021
Q2 | $297M | Sell |
|
|||||
|
2021
Q1 | $329M | Buy |
|
|||||
|
2020
Q4 | $267M | Buy |
|
|||||
|
2020
Q3 | $185M | Buy |
|
|||||
|
2020
Q2 | $175M | Sell |
|
|||||
|
2020
Q1 | $233M | Sell |
|
|||||
|
2019
Q4 | $630M | Buy |
|
|||||
|
2019
Q3 | $382M | Buy |
|
|||||
|
2019
Q2 | $162M | Sell |
|
|||||
|
2019
Q1 | $219M | Buy |
|
|||||
|
2018
Q4 | $118M | Sell |
|
|||||
|
2018
Q3 | $310M | Sell |
|
|||||
|
2018
Q2 | $297M | Buy |
|
|||||
|
2018
Q1 | $226M | Buy |
|
|||||
|
2017
Q4 | $214M | Buy |
|
|||||
|
2017
Q3 | $163M | Sell |
|
|||||
|
2017
Q2 | $412M | Sell |
|
|||||
|
2017
Q1 | $425M | Buy |
|
|||||
|
2016
Q4 | $328M | Sell |
|
|||||
|
2016
Q3 | $627M | Buy |
|
|||||
|
2016
Q2 | $278M | Sell |
|
|||||
|
2016
Q1 | $441M | Buy |
|
|||||
|
2015
Q4 | $401M | Sell |
|
|||||
|
2015
Q3 | $568M | Buy |
|
|||||
|
2015
Q2 | $600M | Buy |
|
|||||
|
2015
Q1 | $506M | Buy |
|
|||||
|
2014
Q4 | $332M | Sell |
|
|||||
|
2014
Q3 | $583M | Buy |
|
|||||
|
2014
Q2 | $432M | Sell |
|
|||||
|
2014
Q1 | $628M | Buy |
|
|||||
|
2013
Q4 | $395M | Buy |
|
|||||
|
2013
Q3 | $207M | Sell |
|
|||||
|
2013
Q2 | $180M | Buy |
|